Brief: SynAct Pharma To Acquire TXP Pharma For SEK 136 Mln

SynAct Pharma AB

12/12/2022 06:40

Dec 12 (Reuters) - SynAct Pharma AB  SYNACT.ST :
    * SYNACT PHARMA TO MAKE STRATEGIC ACQUISITION OF SWISS
BIOTECH
COMPANY TXP PHARMA
    * HAS ENTERED INTO A CONDITIONAL AGREEMENT ON ACQUISITION OF
TXP
PHARMA AG
    * PURCHASE PRICE CONSISTS OF A FIXED PURCHASE PRICE OF SEK
136
MILLION
    * OPTION FOR POTENTIAL ADDITIONAL PURCHASE PRICE OF SEK 55
MILLION

Source text for Eikon:  ID:nMFN65HrF1 
Further company coverage:  SYNACT.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))